1. Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy
   Galatea Kallergi et al, 2022, Cancers CrossRef
2. Detection of PD‑L1 expression and epithelial‑mesenchymal transition of circulating tumor cells in non‑small cell lung cancer
   Jianping Jiang et al, 2024, Experimental and Therapeutic Medicine CrossRef
3. Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival
   Menno Tamminga et al, 2022, British Journal of Cancer CrossRef
4. Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients
   Spyridoula D. Katsarou et al, 2022, Journal of Personalized Medicine CrossRef
5. Advances in Clinical Research on Solid Tumor Circulating Tumor Cells and Their EMT Typing
   维忠 孙, 2022, Advances in Clinical Medicine CrossRef
6. Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC
   Yujuan Zhang et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef